{"data":{"id":"us/21-cfr-357.201","jurisdiction":"us","citation":"21 CFR 357.201","heading":"Scope.","body":"(a) An over-the-counter cholecystokinetic drug product in a form suitable for oral administration is generally recognized as safe and effective and is not misbranded if it meets each of the conditions in this subpart in addition to each of the general conditions established in § 330.1.\n(b) References in this subpart to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 357—MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE","Subpart C—Cholecystokinetic Drug Products"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"29c434563e70c9ecb3131aca63c64bea730274d91e7f5fb50dbd5a058b52b89e","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-357.180","next":"us/21-cfr-357.203"},"notice":"GroundRules: Original legal text. Not legal advice."}